1. Association of the expression of mct1 and mct4 with cell proliferation index and clinical factors of malignant tumors of the oral cavity
- Author
-
Teixeira, Fernanda C?sseres and Cherubini, Karen
- Subjects
C?ncer Oral ,ODONTOLOGIA [CIENCIAS DA SAUDE] ,Lactato ,Oral Cancer ,Lactate ,MCT4 ,MCT1 ,Energy Metabolism ,Malignant Cells ,Metabolismo Energ?tico - Abstract
A multiplica??o celular descontrolada constitui a ess?ncia do comportamento biol?gico das neoplasias malignas e envolve mecanismos altamente complexos. Eventos celulares relacionados ? respira??o s?o respons?veis pela produ??o de energia e, por isso, essenciais ? sobreviv?ncia celular. A compreens?o dos processos neopl?sicos ? um desafio, e o conhecimento de biomarcadores espec?ficos envolvidos na capta??o energ?tica das c?lulas malignas ? crucial para o melhor entendimento do c?ncer. O presente estudo teve por objetivo investigar a express?o dos transportadores de monocarboxilato 1 (MCT1) e 4 (MCT4), bem como sua rela??o com a taxa de prolifera??o celular (Ki67) e caracter?sticas cl?nicas em diferentes tipos histol?gicos de tumores da cavidade oral. Prontu?rios e esp?cimes de bi?psia de tumores orais foram distribu?dos nos seguintes grupos: (1) 14 linfomas; (2) 5 melanomas; (3) 11 adenocarcinomas (prim?rios e met?stases); (4) 15 carcinomas espinocelulares (CEC); e (5) grupo-controle: 15 hiperplasias fibroepiteliais. Os prontu?rios foram revisados considerando idade e sexo dos pacientes; uso de ?lcool e tabaco; sintomas; e s?tio anat?mico, tamanho e tempo de evolu??o das les?es. Os esp?cimes foram submetidos a processamento imunoistoqu?mico para avaliar a express?o dos marcadores MCT1, MCT4 e Ki-67. De modo geral, os tumores orais avaliados tiveram coexpress?o de MCT1 e MCT4, especialmente o CEC e o melanoma. MCT1 e MCT4 exibiram correla??o positiva entre si; MCT1 tamb?m teve correla??o positiva com Ki67, enquanto o MCT4 n?o teve. Os tr?s marcadores exibiram correla??o positiva com tamanho do tumor, enquanto somente o MCT4 teve correla??o negativa com o tempo de evolu??o. Conclus?o: O perfil de express?o dos marcadores MCT1 e MCT4 corrobora sua rela??o com fatores progn?sticos, bem como a participa??o do efeito Warburg reverso no perfil energ?tico do c?ncer oral. S?o necess?rios novos estudos para subsidiar evid?ncias desses fatores como um novo alvo na terap?utica oncol?gica. Uncontrolled cell proliferation is the essence of biological behavior of malignancies, comprising highly complex mechanisms. Cellular processes related to respiration are responsible for the energy production and, therefore, essential for cell surviving. Understanding tumor biology is a challenging task, and the knowledge of biomarkers involved in the energy processes of cancer cells is extremely important to better understand the cancer itself. The aim of the present study was to analyze the expression of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) and the relationship of these transporters to cell proliferation rate (Ki67) and clinical features in malignant tumors of the oral cavity. Paraffin-embedded oral biopsy specimens were allocated into the following groups: (1) 14 lymphomas; (2) 5 melanomas; (3) 11 adenocarcinomas (primary and metastases); (4) 15 squamous cell carcinomas (SCCs); and (5) 15 fibroepithelial hyperplasias (control group). Medical records were reviewed considering patients? age and sex, alcohol and tobacco use, symptoms, and the anatomical site, evolution time and size of the tumor. The immunohistochemical expression of Ki67, MCT1 and MCT4 was analyzed in the sample. Overall, MCT1 and MCT4 were co-expressed in the oral tumors analyzed, especially in SCC and melanoma. MCT1 and MCT4 were positively correlated to each other; MCT1 was also correlated to Ki67, whereas MCT4 was not. These three markers were positively correlated to tumor size, whereas only MCT4 was negatively correlated to the evolution time of the tumor. Conclusion: MCT1 and MCT4 expression supports reverse Warburg effect as an energy profile in oral cancer and its relationship to prognostic factors. Further studies analyzing the specificities of this relationship are needed to provide evidence of a new target in oral oncology therapeutics. Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES
- Published
- 2021